List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #52,861 to #52,910.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. The Living Guidelines: Patients with Reduced LVEF. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
  2. The Living Guidelines: Patients with Reduced LVEF. View the Current CLASS IIb Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
  3. The Living Guidelines: Patients with Reduced LVEF. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
  4. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. View the Current CLASS III Guidelines → Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)
  5. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)
  6. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. View the Current CLASS IIb Guidelines → Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)
  7. The Living Guidelines: Patients with Refractory End-Stage Heart Failure. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)
  8. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): View the Current CLASS III Guidelines → Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes
  9. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): View the Current CLASS IIa Guidelines → Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes
  10. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): View the Current CLASS IIb Guidelines → Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes
  11. The Living Guidelines: Patients with Wolff Parkinson White syndrome (WPW): View the Current CLASS I Guidelines → Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes
  12. The Living Guidelines: Patients with acute myocardial infarction: View the Current CLASS III Guidelines → Atrial fibrillation acute myocardial infarction
  13. The Living Guidelines: Patients with acute myocardial infarction: View the Current CLASS IIa Guidelines → Atrial fibrillation acute myocardial infarction
  14. The Living Guidelines: Patients with acute myocardial infarction: View the Current CLASS I Guidelines → Atrial fibrillation acute myocardial infarction
  15. The Living Guidelines: Patients with hyperthyroidism: View the Current CLASS I Guidelines → Atrial fibrillation hyperthyroidism
  16. The Living Guidelines: Patients with hypertrophic cardiomyopathy: View the Current CLASS IIa Guidelines → Atrial fibrillation hypertrophic cardiomyopathy
  17. The Living Guidelines: Patients with hypertrophic cardiomyopathy: View the Current CLASS I Guidelines → Atrial fibrillation hypertrophic cardiomyopathy
  18. The Living Guidelines: Patients with postoperative atrial fibrillation: View the Current CLASS IIa Guidelines → Postoperative atrial fibrillation
  19. The Living Guidelines: Patients with postoperative atrial fibrillation: View the Current CLASS IIb Guidelines → Postoperative atrial fibrillation
  20. The Living Guidelines: Patients with postoperative atrial fibrillation: View the Current CLASS I Guidelines → Postoperative atrial fibrillation
  21. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation View the Current CLASS III Guidelines → Atrial fibrillation cardioversion
  22. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation View the Current CLASS IIa Guidelines → Atrial fibrillation cardioversion
  23. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation View the Current CLASS IIb Guidelines → Atrial fibrillation cardioversion
  24. The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation View the Current CLASS I Guidelines → Atrial fibrillation cardioversion
  25. The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: View the Current CLASS IIa Guidelines → Atrial fibrillation cardioversion
  26. The Living Guidelines: Pharmacological enhancement of direct-current cardioversion: View the Current CLASS IIb Guidelines → Atrial fibrillation cardioversion
  27. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS III Guidelines → Atrial fibrillation rate control
  28. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS IIa Guidelines → Atrial fibrillation rate control
  29. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS IIb Guidelines → Atrial fibrillation rate control
  30. The Living Guidelines: Pharmacological rate control during atrial fibrillation View the Current CLASS I Guidelines → Atrial fibrillation rate control
  31. The Living Guidelines: Pregnant patients: View the Current CLASS IIb Guidelines → Atrial fibrillation pregnancy
  32. The Living Guidelines: Pregnant patients: View the Current CLASS I Guidelines → Atrial fibrillation pregnancy
  33. The Living Guidelines: Preventing Thromboembolism View the Current CLASS IIa Guidelines → Atrial fibrillation pharmacological treatment
  34. The Living Guidelines: Preventing Thromboembolism View the Current CLASS IIb Guidelines → Atrial fibrillation pharmacological treatment
  35. The Living Guidelines: Preventing Thromboembolism View the Current CLASS I Guidelines → Atrial fibrillation pharmacological treatment
  36. The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: View the Current CLASS IIa Guidelines → Atrial fibrillation cardioversion
  37. The Living Guidelines: Prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion: View the Current CLASS I Guidelines → Atrial fibrillation cardioversion
  38. The Living Guidelines: Recommendations for Alternative Therapies for Chronic Stable Angina in Patients Refractory to Medical Therapy Who Are Not Candidates for PCI or Surgical RevascularizationView the Current CLASS IIb Guidelines → Chronic stable angina treatment
  39. The Living Guidelines: Recommendations for Alternative Therapies for Chronic Stable Angina in Patients Refractory to Medical Therapy Who Are Not Candidates for PCI or Surgical Revascularization View the Current CLASS IIa Guidelines → Chronic stable angina treatment
  40. The Living Guidelines: Recommendations for Echocardiography, Treadmill Exercise Testing, Stress Radionuclide Imaging, Stress Echocardiography Studies, and Coronary Angiography during Patient Follow-up View the Current CLASS III Guidelines → Chronic stable angina patient follow-up
  41. The Living Guidelines: Recommendations for Echocardiography, Treadmill Exercise Testing, Stress Radionuclide Imaging, Stress Echocardiography Studies, and Coronary Angiography during Patient Follow-up View the Current CLASS IIa Guidelines → Chronic stable angina patient follow-up
  42. The Living Guidelines: Recommendations for Echocardiography, Treadmill Exercise Testing, Stress Radionuclide Imaging, Stress Echocardiography Studies, and Coronary Angiography during Patient Follow-up View the Current CLASS IIb Guidelines → Chronic stable angina patient follow-up
  43. The Living Guidelines: Recommendations for Monitoring of symptoms and anti anginal therapy during follow up View the Current CLASS III Guidelines → Chronic stable angina patient follow-up
  44. The Living Guidelines: Recommendations for Monitoring of symptoms and anti anginal therapy during follow up View the Current CLASS IIb Guidelines → Chronic stable angina patient follow-up
  45. The Living Guidelines: Recommendations for Monitoring of symptoms and anti anginal therapy during follow up View the Current CLASS I Guidelines → Chronic stable angina patient follow-up
  46. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Asymptomatic Patients View the Current CLASS III Guidelines → Chronic stable angina treatment
  47. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Asymptomatic Patients View the Current CLASS IIa Guidelines → Chronic stable angina treatment
  48. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Asymptomatic Patients View the Current CLASS IIb Guidelines → Chronic stable angina treatment
  49. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Asymptomatic Patients View the Current CLASS I Guidelines → Chronic stable angina treatment
  50. The Living Guidelines: Recommendations for Revascularization with PCI and CABG in Patients with Chronic Stable Angina View the Current CLASS III Guidelines → Chronic stable angina treatment

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"